Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
Jeffrey A. Lieberman, Scott A. Small, Ragy R. Girgis
American Journal of Psychiatry (2019) Vol. 176, Iss. 10, pp. 794-810
Closed Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study
Chengdong Wang, Dongdong Zhu, Zhang Dong-jun, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 199
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses
Thomas D. Als, Mitja Kurki, Jakob Grove, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1832-1844
Open Access | Times Cited: 150
Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis
Carmen Schiweck, Gara Arteaga-Henríquez, Mareike Aichholzer, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 124, pp. 100-123
Closed Access | Times Cited: 116
Future of Digital Assays to Resolve Clinical Heterogeneity of Single Extracellular Vesicles
Renee‐Tyler T. Morales, Jina Ko
ACS Nano (2022) Vol. 16, Iss. 8, pp. 11619-11645
Open Access | Times Cited: 78
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review
Andrea Perrottelli, Giulia Maria Giordano, Francesco Brando, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 79
Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder
Mikaïl Nourredine, Adrien Gering, Pierre Fourneret, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 5, pp. 519-519
Open Access | Times Cited: 69
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia
Inès Khadimallah, Raoul Jenni, Jan-Harry Cabungcal, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1192-1204
Open Access | Times Cited: 59
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis
Donal O’Keeffe, Anthony Kinsella, John L. Waddington, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 288-297
Closed Access | Times Cited: 48
Radix Bupleuri aqueous extract attenuates MK801-induced schizophrenia-like symptoms in mice: Participation of intestinal flora
Ping Yang, Sheng Huang, Zhihong Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116267-116267
Open Access | Times Cited: 8
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
Valerie J. Sydnor, David R. Roalf
Schizophrenia Research (2020) Vol. 226, pp. 61-69
Open Access | Times Cited: 56
Practitioner Review: Psychosis in children and adolescents
Anna B. Sunshine, Jon McClellan
Journal of Child Psychology and Psychiatry (2023) Vol. 64, Iss. 7, pp. 980-988
Open Access | Times Cited: 17
Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies
Gonzalo Salazar de Pablo, Daniel Guinart, Alvaro Armendariz, et al.
Schizophrenia Bulletin (2024) Vol. 50, Iss. 4, pp. 771-783
Open Access | Times Cited: 7
Progression from being at-risk to psychosis: next steps
Jean Addington, Megan S. Farris, Daniel J. Devoe, et al.
Schizophrenia (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 48
What is the duration of untreated psychosis worldwide? – A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies
Gonzalo Salazar de Pablo, Clàudia Aymerich, Daniel Guinart, et al.
Psychological Medicine (2023) Vol. 54, Iss. 4, pp. 652-662
Open Access | Times Cited: 15
Speech markers to predict and prevent recurrent episodes of psychosis: A narrative overview and emerging opportunities
Farida Zaher, Mariama Dalanda Diallo, Amélie M. Achim, et al.
Schizophrenia Research (2024) Vol. 266, pp. 205-215
Closed Access | Times Cited: 5
Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics
Hui-ping Shen, Xiaotao Dong, Zhibin Li, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 7, pp. 2376-2385
Closed Access | Times Cited: 5
Schizophrenia and cancer: Insights into psychiatric nursing care
Harumi Arai, Ng Chong Guan, Weng Hou Siew, et al.
Archives of Psychiatric Nursing (2025)
Open Access
Metrics of two-dimensional smooth pursuit are diverse across participants and stable across days
Yuxin Yan, Yuxiang Wu, Hoi Ming Ken Yip, et al.
Journal of Vision (2025) Vol. 25, Iss. 2, pp. 5-5
Open Access
Bioinformatics-based identification of CTSS, DOK2, and ENTPD1 as potential blood biomarkers of schizophrenia
Lei Zhang, Jiale Zhang, Na Wang, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Ecological and Momentary Assessment and Intervention for Schizophrenia: Use of Smartphone Apps and Video Games
Takeshi Sakurai, Michel Birnbaum, Yi Han Victoria Chua, et al.
(2025)
Closed Access
Using dimensionality-reduction techniques to understand the organization of psychotic symptoms in persistent psychotic illness and first episode psychosis
Leah Fleming, Ann Catherine Lemonde, David Benrimoh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls
Àlex G. Segura, Elena de la Serna, Gisela Sugranyes, et al.
European Neuropsychopharmacology (2024) Vol. 81, pp. 28-37
Open Access | Times Cited: 4
The Impact of Prolonged Duration of Untreated Illness on Clinical Correlates in Chronic Schizophrenia: Exploring the Relationship With Suicide Risk
K. Zhang, C. Wang, Lei Gou, et al.
Psychiatry Investigation (2024) Vol. 21, Iss. 4, pp. 422-432
Open Access | Times Cited: 4
Relationship of metabolites and metabolic ratios with schizophrenia: a mendelian randomization study
Yu Huang, Han-Xuan Wang, Jiayu Zheng, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Impact of age of onset on the course of chronic schizophrenia: factors associated with first hospitalization in a large-scale cross-sectional study
Qingling Hao, Yuan Yang, Shutong Yang, et al.
European Archives of Psychiatry and Clinical Neuroscience (2025)
Closed Access
Page 1 - Next Page

Scroll to top